=== Ticker Info ===
address1	No. 1, Nan-Ke 8th Road
address2	Southern Taiwan Science Park Shan-Hua
city	Tainan City
zip	74144
country	Taiwan
phone	886 6 505 2888
fax	886 6 505 2898
website	https://www.scinopharm.com
industry	Drug Manufacturers - Specialty & Generic
industryKey	drug-manufacturers-specialty-generic
industryDisp	Drug Manufacturers - Specialty & Generic
sector	Healthcare
sectorKey	healthcare
sectorDisp	Healthcare
longBusinessSummary	ScinoPharm Taiwan, Ltd., together with its subsidiaries, researches and develops, produces, and sells cGMP active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, the United States, Europe, India, rest of Asia, Taiwan, and internationally. The company offers small molecular drugs, complex natural molecules and derivatives, synthesis services for biochemistry molecules, such as peptides and nucleic acids; generic API manufacturing services; and outsourcing services. It also provides CRAM services, such as chemistry skill, analytical and regulatory, chemical process development, clinical drug substance, and consulting services for the development and manufacturing of clinical, small-scale, and commercial-stage APIs and intermediates. In addition, the company develops peptide synthesis technologies. Further, the company develops and manufactures western medicines and other chemical materials, albumin medicines, oligonucleotide medicines, injections, and new small molecule drugs, as well as provides biological technology services and technical services. It has a strategic alliance with Baxter International Inc. to develop, manufacture, and commercialize of antiemetic drug in chemotherapy for cancer. ScinoPharm Taiwan, Ltd. was incorporated in 1997 and is headquartered in Tainan City, Taiwan.
companyOfficers	[{'maxAge': 1, 'name': 'Mr. Chih-Hsien  Lo', 'age': 66, 'title': 'Chairman & General Chief Strategy Officer', 'yearBorn': 1957, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Li-An  Lu', 'title': 'President & CEO', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Chih-Hui  Lin', 'title': 'Acting Financial Off., Senior Director of Acct., Acct. Off., Acting Spokesperson & Corp. Gov. Off.', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ling-Hsiao  Lien', 'title': 'Vice-President of Operations', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Li-Chiao  Chang Chemistry, Ph.D.', 'title': 'VP of R&D Division and Chief Scientific Officer', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jason  Chen', 'title': 'Director of Human Resources & Admin', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Ching-Wen  Lin B.S, M.S, Ph.D.', 'title': 'VP of Marketing & Sales and Chief Strategy Officer', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Shun Yang  Lin', 'title': 'Director of Corporate Development', 'exercisedValue': 0, 'unexercisedValue': 0}]
maxAge	86400
priceHint	2
previousClose	27.6
open	27.4
dayLow	27.4
dayHigh	27.85
regularMarketPreviousClose	27.6
regularMarketOpen	27.4
regularMarketDayLow	27.4
regularMarketDayHigh	27.85
dividendRate	0.36
dividendYield	0.013099999
exDividendDate	1688601600	 (2023-07-06 08:00:00)
payoutRatio	0.7347
fiveYearAvgDividendYield	1.61
beta	0.298
trailingPE	56.224487
forwardPE	105.96154
volume	685951
regularMarketVolume	685951
averageVolume	1331036
averageVolume10days	1277059
averageDailyVolume10Day	1277059
bid	27.55
ask	27.6
marketCap	21784858624
fiftyTwoWeekLow	24.3
fiftyTwoWeekHigh	35.8
priceToSalesTrailing12Months	6.837505
fiftyDayAverage	26.975
twoHundredDayAverage	26.9745
trailingAnnualDividendRate	0.3
trailingAnnualDividendYield	0.010869565
currency	TWD
enterpriseValue	18463258624
profitMargins	0.090100005
floatShares	245310960
sharesOutstanding	790739008
heldPercentInsiders	0.58742
heldPercentInstitutions	0.16924
impliedSharesOutstanding	793542976
bookValue	13.107
priceToBook	2.1019301
lastFiscalYearEnd	1703980800	 (2023-12-31 08:00:00)
nextFiscalYearEnd	1735603200	 (2024-12-31 08:00:00)
mostRecentQuarter	1703980800	 (2023-12-31 08:00:00)
earningsQuarterlyGrowth	0.549
netIncomeToCommon	287056000
trailingEps	0.49
forwardEps	0.26
lastSplitFactor	1040:1000
lastSplitDate	1502323200	 (2017-08-10 08:00:00)
enterpriseToRevenue	5.795
enterpriseToEbitda	24.3
52WeekChange	0.06370652
SandP52WeekChange	0.26265144
lastDividendValue	0.36
lastDividendDate	1688601600	 (2023-07-06 08:00:00)
exchange	TAI
quoteType	EQUITY
symbol	1789.TW
underlyingSymbol	1789.TW
shortName	SCINOPHARM TAIWAN LTD
longName	ScinoPharm Taiwan, Ltd.
firstTradeDateEpochUtc	1317258000	 (2011-09-29 09:00:00)
timeZoneFullName	Asia/Taipei
timeZoneShortName	CST
uuid	bd1a8e04-2ee8-37cb-b2ad-8ad20dcc3939
messageBoardId	finmb_23777499
gmtOffSetMilliseconds	28800000
currentPrice	27.55
recommendationMean	3.0
recommendationKey	hold
totalCash	3941523968
totalCashPerShare	4.985
ebitda	759819008
totalDebt	619923968
quickRatio	6.519
currentRatio	8.747
totalRevenue	3186083072
debtToEquity	5.981
revenuePerShare	4.029
returnOnAssets	0.01663
returnOnEquity	0.027579999
freeCashflow	-74002000
operatingCashflow	231126000
earningsGrowth	0.549
revenueGrowth	0.106
grossMargins	0.38166
ebitdaMargins	0.23848
operatingMargins	0.17059
financialCurrency	TWD
trailingPegRatio	None

=== Financials ===
                                                                  2023-12-31        2022-12-31        2021-12-31        2020-12-31
Tax Effect Of Unusual Items                                     11866.552001     -26315.608731     -24126.357158      46693.691859
Tax Rate For Calcs                                                  0.177113          0.193497          0.194567          0.213213
Normalized EBITDA                                                819087000.0       885474000.0       690490000.0       766649000.0
Total Unusual Items                                                  67000.0         -136000.0         -124000.0          219000.0
Total Unusual Items Excluding Goodwill                               67000.0         -136000.0         -124000.0          219000.0
Net Income From Continuing Operation Net Minority Interest       287056000.0       353216000.0       243471000.0       282067000.0
Reconciled Depreciation                                          461167000.0       439465000.0       381532000.0       393197000.0
Reconciled Cost Of Revenue                                      1970094000.0      2013273000.0      1481848000.0      1765469000.0
EBITDA                                                           819154000.0       885338000.0       690366000.0       766868000.0
EBIT                                                             357987000.0       445873000.0       308834000.0       373671000.0
Net Interest Income                                               44481000.0        14207000.0        12832000.0        12242000.0
Interest Expense                                                   9147000.0         7913000.0         6548000.0        15166000.0
Interest Income                                                   53628000.0        22120000.0        19380000.0        27408000.0
Normalized Income                                           287000866.552001  353325684.391269  243570873.642842  281894693.691859
Net Income From Continuing And Discontinued Operation            287056000.0       353216000.0       243471000.0       282067000.0
Total Expenses                                                  2871659000.0      2858412000.0      2473592000.0      2707424000.0
Diluted Average Shares                                           792328000.0       792681000.0       792284000.0       792189000.0
Basic Average Shares                                             790739000.0       790739000.0       790739000.0       790739000.0
Diluted EPS                                                             0.36              0.45              0.31              0.36
Basic EPS                                                               0.36              0.45              0.31              0.36
Diluted NI Availto Com Stockholders                              287056000.0       353216000.0       243471000.0       282067000.0
Net Income Common Stockholders                                   287056000.0       353216000.0       243471000.0       282067000.0
Otherunder Preferred Stock Dividend                                      0.0               0.0               0.0               0.0
Net Income                                                       287056000.0       353216000.0       243471000.0       282067000.0
Net Income Including Noncontrolling Interests                    287056000.0       353216000.0       243471000.0       282067000.0
Net Income Continuous Operations                                 287056000.0       353216000.0       243471000.0       282067000.0
Tax Provision                                                     61784000.0        84744000.0        58815000.0        76438000.0
Pretax Income                                                    348840000.0       437960000.0       302286000.0       358505000.0
Other Non Operating Income Expenses                              -10132000.0        18256000.0          835000.0       -29460000.0
Special Income Charges                                               67000.0         -136000.0         -124000.0          219000.0
Write Off                                                           -67000.0          136000.0          124000.0         -219000.0
Net Non Operating Interest Income Expense                         44481000.0        14207000.0        12832000.0        12242000.0
Interest Expense Non Operating                                     9147000.0         7913000.0         6548000.0        15166000.0
Interest Income Non Operating                                     53628000.0        22120000.0        19380000.0        27408000.0
Operating Income                                                 314424000.0       405633000.0       288743000.0       375504000.0
Operating Expense                                                901565000.0       845139000.0       991744000.0       941955000.0
Research And Development                                         357740000.0       271264000.0       305953000.0       245633000.0
Selling General And Administration                               543825000.0       573875000.0       685791000.0       696322000.0
Selling And Marketing Expense                                    179651000.0       167343000.0       153566000.0       170904000.0
General And Administrative Expense                               364174000.0       406532000.0       532225000.0       525418000.0
Gross Profit                                                    1215989000.0      1250772000.0      1280487000.0      1317459000.0
Cost Of Revenue                                                 1970094000.0      2013273000.0      1481848000.0      1765469000.0
Total Revenue                                                   3186083000.0      3264045000.0      2762335000.0      3082928000.0
Operating Revenue                                               3186083000.0      3264045000.0      2762335000.0      3082928000.0